Brief: Curevac Strengthens Ongoing Patent Litigations Against Pfizer/BioNTech
13/07/2023 12:03
July 13 (Reuters) - Curevac Nv 5CV.DE :
* CUREVAC STRENGTHENS ONGOING PATENT LITIGATIONS BRINGING
ADDITIONAL CASESUNDER NEW INTELLECTUAL PROPERTY RIGHTS
* THREE NEW INTELLECTUAL PROPERTY RIGHTS ADDED TO
INFRINGEMENT
LAWSUIT AGAINST PFIZER/BIONTECH IN GERMANY
Source text for Eikon: ID:nEQWLwh4a
Further company coverage: 5CV.DE
((frankfurt.newsroom@thomsonreuters.com;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028